SU-DHL-5 (ATCC® CRL-2958)

Organism: Homo sapiens, human  /  Tissue: Organ: lymph node
Derived from Metastatic Site: peritoneal effusion
 /  Cell Type: B lymphocyte

Permits Notice: Necessary Permits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Organism Homo sapiens, human
Tissue Organ: lymph node
Derived from Metastatic Site: peritoneal effusion
Cell Type B lymphocyte
Morphology lymphoblast-like
Culture Properties suspension, multicell aggregates and single cells
Biosafety Level 1
Age 17 years
Storage Conditions liquid nitrogen vapor phase
Karyotype Human hyperdiploid karyotype with 1.5% polyploidy - 47(41-48)<2n>XX, +12, del(6)(q13), del(12)(q13) - sideline with del(6)x2
Clinical Data 17 years
Female
Caucasian
Receptor Expression Surface Receptors: Fc (not expressed), IgMEAC (not expressed), IgGEA (not expressed), E (not expressed)
Genes Expressed Fc (not expressed),   IgMEAC  (not expressed), IgGEA (not expressed), E  (not expressed)
Comments This cell line is negative for Candida ingestion.
The depositor states that this cell line is negative for Epstein-Barr Virus (EBV).
ATCC confirmed this cell line is negative for the presence of Epstein-Barr viral DNA sequences via PCR.
Complete Growth Medium The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing Protocol:Cultures can be maintained by addition of fresh medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 5 X 104 to 1 X 105 viable cells/ mL. Maintain cultures at a cell concentration below 5 X 105 viable cells/ mL.
Medium renewal: Two to three times weekly
Culture Conditions

Temperature: 37.0°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%

STR Profile
D5S818: 12, 15
D13S317: 12
D7S820: 10
D16S539: 11, 13
vWA: 17
TH01: 6, 9
Amelogenin: X
TPOX: 8
CSF1PO: 11, 13
Year of Origin 1978
References

Epstein AL, et al. Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines. Cancer. 42(5): 2379-2391, 1978. PubMed: 214220

Kaiser-McCaw Hecht B, et al. Histiocytic lymphoma cell lines: immunologic and cytogenetic studies. Cancer Genet. Cytogenet. 14 (3-4): 205-218, 1985. PubMed: 3881165

Siminovitch KA, et al. Immunoglobulin gene rearrangements and expression in diffuse histiocytic lymphomas reveal cellular lineage, molecular defects, and sites of chromosomal translocation. Blood. 67(2): 391-397, 1986. PubMed: 3080039

Epstein AL, Kaplan HS. Feeder layer and nutritional requirements for the establishment and cloning of human malignant lymphoma cell lines. Cancer Res. 39(5):1748-1759, 1979. PubMed: 371794

Permits Notice: Necessary Permits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
References

Epstein AL, et al. Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines. Cancer. 42(5): 2379-2391, 1978. PubMed: 214220

Kaiser-McCaw Hecht B, et al. Histiocytic lymphoma cell lines: immunologic and cytogenetic studies. Cancer Genet. Cytogenet. 14 (3-4): 205-218, 1985. PubMed: 3881165

Siminovitch KA, et al. Immunoglobulin gene rearrangements and expression in diffuse histiocytic lymphomas reveal cellular lineage, molecular defects, and sites of chromosomal translocation. Blood. 67(2): 391-397, 1986. PubMed: 3080039

Epstein AL, Kaplan HS. Feeder layer and nutritional requirements for the establishment and cloning of human malignant lymphoma cell lines. Cancer Res. 39(5):1748-1759, 1979. PubMed: 371794